← Back
$OLMA All transactions

Olema Pharmaceuticals, Inc.

A

$ Value

$0

Shares

850,000

Price

$0

Filed

Feb 4

Insider

Name

Bohen Sean

Title

PRESIDENT AND CEO

CIK

0001831218

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-02

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

850,000

Footnotes

25% of the shares subject to the option vest on February 2, 2027, and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. | The performance-based stock options will be eligible to vest during two distinct performance periods, each beginning on February 2, 2026 and ending on December 31, 2029 and December 31, 2030, respectively, based on the Issuer's stock price trading at certain pre-determined price thresholds as measured by the average closing price per share of the Issuer's stock over a consecutive thirty (30) day trading period during each such performance period. Once a price threshold is achieved, the portion of the award related to such threshold will vest upon the date set forth in the certification by the Compensation Committee certifying that such price threshold was achieved, subject to the Reporting Person's continuous service as of the applicable certification date. | Notwithstanding the foregoing, if the Reporting Person's continuous service is terminated without Cause (as defined in the Reporting Person's offer letter), the performance-based stock options shall remain outstanding and eligible to vest for twelve (12) months following such termination.

Filing Info

Accession No.

0001831218-26-000002

Form Type

4

Issuer CIK

0001750284

Bohen Sean's History

Date Ticker Type Value
2026-02-02 OLMA A $0
2026-02-02 OLMA A $0
2025-12-26 OLMA G $0

Other Insiders at OLMA (90d)

Insider Bought Sold Last
Mitchell Shawnte
CHIEF LEGAL OFFICER
$952K 2026-03-04
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
2026-02-02
Bohen Sean
PRESIDENT AND CEO
2026-02-02
Zojwalla Naseem
CHIEF MEDICAL OFFICER
2026-02-02
Austin Sasha Lu
VP of Finance and Controller
2026-02-02